The Vagus Nerve Stimulator Market is expected to register a CAGR of 10.3% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented By Product (Implantable VNS Devices, External VNS Devices); Application (Depression, Epilepsy, Migraine); End User (Hospitals, Ambulatory Surgical Centers (ASCs), Others); Biomaterial (Ceramics, Metallic, Polymeric). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Vagus Nerve Stimulator Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Vagus Nerve Stimulator Market Segmentation
Product- Implantable VNS Devices
- External VNS Devices
- Depression
- Epilepsy
- Migraine
- Hospitals
- Ambulatory Surgical Centers
- Ceramics
- Metallic
- Polymeric
Strategic Insights
Vagus Nerve Stimulator Market Growth Drivers- Growing Prevalence of Neurological Disorders: Epilepsy and depression are among the neurological disorders which are known to have an increasing prevalence, therefore contribute to the vagus nerve stimulator market growth. As more patients come looking for treatments, the need for new therapies is on the rise. Vagus nerve stimulators are effective alternatives for patients who do not respond to regular drugs and therefore they are embraced by both the healthcare givers and the patients.
- Advances in Medical Technology: The vagus nerve stimulator market is also being driven by advances in medical technology. Improvements in device design and programming, as well as minimally invasive surgical procedures, increase the performance and safety of these stimulators. Further as technology progresses, so do the appliances diversified by manufacturers leading to better outcomes and consequently better utilization and broader market draws.
- Increased Focus on Mental Health Treatments: The rising trends in mental health treatment are also contributing to the growing market for vagus nerve stimulators especially in the management of depression and anxiety. With the rise in awareness of these issues, the health care providers have begun searching for therapies that will help solve these problems. Clinical trials have been successful with the use of vagus nerve stimulation, hence this treatment method gained popularity and funding in the field of mental health.
- Shift Towards Non-Invasive Techniques: One more remarkable thing to note in the market for vagus nerve stimulators is how it has been noted that there is a steady transition or change from the invasive procedures to the non-invasive methods. New devices, for example, transcutaneous vagus nerve stimulators, allow patients to receive adequate treatment without the need for surgical procedures. This trend is beneficial to patients and health care providers as well since non-invasive techniques are less risky and they cut down the recovery period and thus vagus nerve stimulation can be easily and widely practiced in hospitals.
- Integration of Digital Health Technologies: The vagus nerve stimulator market has a lot to benefit from the incorporation of digital health technologies. Companies have developed measures whereby the patients are monitored remotely and even mobile applications have been developed to gauge the effectiveness of the device in question. This trend improves the level of involvement of the patients as well but the other health care providers are able to modify the treatment of the patients when need arises improving the quality of care offered.
- Focus on Personalized Medicine: Personalized health care is becoming the new paradigm in the vagus nerve stimulators market. This approach is effective and its benefits are starting to be appreciated by many health care practitioners. While utilizing vagus nerve stimulation, clinicians can increase adherence and satisfaction of patients by varying stimulation parameters according to individual patient’s and condition responses.
- Expansion into Emerging Markets: Emerging markets offer a substantial potential to the vagus nerve stimulator market. As the healthcare system improves and more people become aware of neurological disorders, the market experiences an upsurge in the in the demand for new treatment modalities. Such markets can be tapped by the manufacturers through associations with local health care providers at their net prices making vagus nerve stimulation therapies more available into those markets marketed thus enhancing health.
- Development of Combination Therapies: This presents an additional avenue for market development, namely, the promotion research of combined treatment with patients’ therapy stimulation involving the vagus nerve. Most studies now concentrate on cochlear implantation in conjunction with pharmacotherapy or cognitive behavioral therapies, explanting the patient’s vagus nerve stimulators. Such approach allows a more effective treatment for such diseases as depression and epilepsy, which makes the vagus nerve stimulation more appealing for not only the patients but also the healthcare providers.
- Innovation in Device Technology: The continuous advancement of device technology offers a tremendous market opportunity for vagus nerve stimulator. New dimensions such as reduction in size, enhanced battery power and operability software can pave way for the creation of sophisticated and easy to use devices. Firms can incorporate research and development and develop more advanced stimulators that address the changing demands of patients and medical practitioners, hence accelerating the growth of the market.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Vagus Nerve Stimulator Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Vagus Nerve Stimulator Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Growing prevalence of neurological disorders and advances in medical technology is the major factors boosting the vagus nerve stimulator market growth
Aleva Neurotherapeutics SA, BioControl Medical, Bioness Inc., Boston Scientific Corporation, ElectroCore LLC, EnteroMedics Inc., LivaNova Plc., Medtronic Plc., NeuroPace Inc., Nevro Corporation are the some of the key market players operating in the vagus nerve stimulator market
The market is expected to grow at a CAGR of 10.3%
The North America region accounts for highest revenue share vagus nerve stimulator market
The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional
/
country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)
Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023 - 2031)
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3.MARKET SEGMENTATION
1.3.1 Vagus Nerve Stimulation Market - By Product
1.3.2 Vagus Nerve Stimulation Market - By Application
1.3.3 Vagus Nerve Stimulation Market - By End User
1.3.4 Vagus Nerve Stimulation Market - By Biomaterial
1.3.5 Vagus Nerve Stimulation Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VAGUS NERVE STIMULATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VAGUS NERVE STIMULATION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VAGUS NERVE STIMULATION MARKET - GLOBAL MARKET ANALYSIS
6.1. VAGUS NERVE STIMULATION - GLOBAL MARKET OVERVIEW
6.2. VAGUS NERVE STIMULATION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. VAGUS NERVE STIMULATION MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. IMPLANTABLE VNS DEVICES
7.3.1. Overview
7.3.2. Implantable VNS Devices Market Forecast and Analysis
7.4. EXTERNAL VNS DEVICES
7.4.1. Overview
7.4.2. External VNS Devices Market Forecast and Analysis
8. VAGUS NERVE STIMULATION MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DEPRESSION
8.3.1. Overview
8.3.2. Depression Market Forecast and Analysis
8.4. EPILEPSY
8.4.1. Overview
8.4.2. Epilepsy Market Forecast and Analysis
8.5. MIGRAINE
8.5.1. Overview
8.5.2. Migraine Market Forecast and Analysis
9. VAGUS NERVE STIMULATION MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. AMBULATORY SURGICAL CENTERS (ASCS)
9.4.1. Overview
9.4.2. Ambulatory Surgical Centers (ASCs) Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. VAGUS NERVE STIMULATION MARKET - REVENUE AND FORECASTS TO 2028 - BIOMATERIAL
10.1. OVERVIEW
10.2. BIOMATERIAL MARKET FORECASTS AND ANALYSIS
10.3. CERAMICS
10.3.1. Overview
10.3.2. Ceramics Market Forecast and Analysis
10.4. METALLIC
10.4.1. Overview
10.4.2. Metallic Market Forecast and Analysis
10.5. POLYMERIC
10.5.1. Overview
10.5.2. Polymeric Market Forecast and Analysis
11. VAGUS NERVE STIMULATION MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Vagus Nerve Stimulation Market Overview
11.1.2 North America Vagus Nerve Stimulation Market Forecasts and Analysis
11.1.3 North America Vagus Nerve Stimulation Market Forecasts and Analysis - By Product
11.1.4 North America Vagus Nerve Stimulation Market Forecasts and Analysis - By Application
11.1.5 North America Vagus Nerve Stimulation Market Forecasts and Analysis - By End User
11.1.6 North America Vagus Nerve Stimulation Market Forecasts and Analysis - By Biomaterial
11.1.7 North America Vagus Nerve Stimulation Market Forecasts and Analysis - By Countries
11.1.7.1 United States Vagus Nerve Stimulation Market
11.1.7.1.1 United States Vagus Nerve Stimulation Market by Product
11.1.7.1.2 United States Vagus Nerve Stimulation Market by Application
11.1.7.1.3 United States Vagus Nerve Stimulation Market by End User
11.1.7.1.4 United States Vagus Nerve Stimulation Market by Biomaterial
11.1.7.2 Canada Vagus Nerve Stimulation Market
11.1.7.2.1 Canada Vagus Nerve Stimulation Market by Product
11.1.7.2.2 Canada Vagus Nerve Stimulation Market by Application
11.1.7.2.3 Canada Vagus Nerve Stimulation Market by End User
11.1.7.2.4 Canada Vagus Nerve Stimulation Market by Biomaterial
11.1.7.3 Mexico Vagus Nerve Stimulation Market
11.1.7.3.1 Mexico Vagus Nerve Stimulation Market by Product
11.1.7.3.2 Mexico Vagus Nerve Stimulation Market by Application
11.1.7.3.3 Mexico Vagus Nerve Stimulation Market by End User
11.1.7.3.4 Mexico Vagus Nerve Stimulation Market by Biomaterial
11.2. EUROPE
11.2.1 Europe Vagus Nerve Stimulation Market Overview
11.2.2 Europe Vagus Nerve Stimulation Market Forecasts and Analysis
11.2.3 Europe Vagus Nerve Stimulation Market Forecasts and Analysis - By Product
11.2.4 Europe Vagus Nerve Stimulation Market Forecasts and Analysis - By Application
11.2.5 Europe Vagus Nerve Stimulation Market Forecasts and Analysis - By End User
11.2.6 Europe Vagus Nerve Stimulation Market Forecasts and Analysis - By Biomaterial
11.2.7 Europe Vagus Nerve Stimulation Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Vagus Nerve Stimulation Market
11.2.7.1.1 Germany Vagus Nerve Stimulation Market by Product
11.2.7.1.2 Germany Vagus Nerve Stimulation Market by Application
11.2.7.1.3 Germany Vagus Nerve Stimulation Market by End User
11.2.7.1.4 Germany Vagus Nerve Stimulation Market by Biomaterial
11.2.7.2 France Vagus Nerve Stimulation Market
11.2.7.2.1 France Vagus Nerve Stimulation Market by Product
11.2.7.2.2 France Vagus Nerve Stimulation Market by Application
11.2.7.2.3 France Vagus Nerve Stimulation Market by End User
11.2.7.2.4 France Vagus Nerve Stimulation Market by Biomaterial
11.2.7.3 Italy Vagus Nerve Stimulation Market
11.2.7.3.1 Italy Vagus Nerve Stimulation Market by Product
11.2.7.3.2 Italy Vagus Nerve Stimulation Market by Application
11.2.7.3.3 Italy Vagus Nerve Stimulation Market by End User
11.2.7.3.4 Italy Vagus Nerve Stimulation Market by Biomaterial
11.2.7.4 Spain Vagus Nerve Stimulation Market
11.2.7.4.1 Spain Vagus Nerve Stimulation Market by Product
11.2.7.4.2 Spain Vagus Nerve Stimulation Market by Application
11.2.7.4.3 Spain Vagus Nerve Stimulation Market by End User
11.2.7.4.4 Spain Vagus Nerve Stimulation Market by Biomaterial
11.2.7.5 United Kingdom Vagus Nerve Stimulation Market
11.2.7.5.1 United Kingdom Vagus Nerve Stimulation Market by Product
11.2.7.5.2 United Kingdom Vagus Nerve Stimulation Market by Application
11.2.7.5.3 United Kingdom Vagus Nerve Stimulation Market by End User
11.2.7.5.4 United Kingdom Vagus Nerve Stimulation Market by Biomaterial
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Vagus Nerve Stimulation Market Overview
11.3.2 Asia-Pacific Vagus Nerve Stimulation Market Forecasts and Analysis
11.3.3 Asia-Pacific Vagus Nerve Stimulation Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Vagus Nerve Stimulation Market Forecasts and Analysis - By Application
11.3.5 Asia-Pacific Vagus Nerve Stimulation Market Forecasts and Analysis - By End User
11.3.6 Asia-Pacific Vagus Nerve Stimulation Market Forecasts and Analysis - By Biomaterial
11.3.7 Asia-Pacific Vagus Nerve Stimulation Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Vagus Nerve Stimulation Market
11.3.7.1.1 Australia Vagus Nerve Stimulation Market by Product
11.3.7.1.2 Australia Vagus Nerve Stimulation Market by Application
11.3.7.1.3 Australia Vagus Nerve Stimulation Market by End User
11.3.7.1.4 Australia Vagus Nerve Stimulation Market by Biomaterial
11.3.7.2 China Vagus Nerve Stimulation Market
11.3.7.2.1 China Vagus Nerve Stimulation Market by Product
11.3.7.2.2 China Vagus Nerve Stimulation Market by Application
11.3.7.2.3 China Vagus Nerve Stimulation Market by End User
11.3.7.2.4 China Vagus Nerve Stimulation Market by Biomaterial
11.3.7.3 India Vagus Nerve Stimulation Market
11.3.7.3.1 India Vagus Nerve Stimulation Market by Product
11.3.7.3.2 India Vagus Nerve Stimulation Market by Application
11.3.7.3.3 India Vagus Nerve Stimulation Market by End User
11.3.7.3.4 India Vagus Nerve Stimulation Market by Biomaterial
11.3.7.4 Japan Vagus Nerve Stimulation Market
11.3.7.4.1 Japan Vagus Nerve Stimulation Market by Product
11.3.7.4.2 Japan Vagus Nerve Stimulation Market by Application
11.3.7.4.3 Japan Vagus Nerve Stimulation Market by End User
11.3.7.4.4 Japan Vagus Nerve Stimulation Market by Biomaterial
11.3.7.5 South Korea Vagus Nerve Stimulation Market
11.3.7.5.1 South Korea Vagus Nerve Stimulation Market by Product
11.3.7.5.2 South Korea Vagus Nerve Stimulation Market by Application
11.3.7.5.3 South Korea Vagus Nerve Stimulation Market by End User
11.3.7.5.4 South Korea Vagus Nerve Stimulation Market by Biomaterial
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Vagus Nerve Stimulation Market Overview
11.4.2 Middle East and Africa Vagus Nerve Stimulation Market Forecasts and Analysis
11.4.3 Middle East and Africa Vagus Nerve Stimulation Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Vagus Nerve Stimulation Market Forecasts and Analysis - By Application
11.4.5 Middle East and Africa Vagus Nerve Stimulation Market Forecasts and Analysis - By End User
11.4.6 Middle East and Africa Vagus Nerve Stimulation Market Forecasts and Analysis - By Biomaterial
11.4.7 Middle East and Africa Vagus Nerve Stimulation Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Vagus Nerve Stimulation Market
11.4.7.1.1 South Africa Vagus Nerve Stimulation Market by Product
11.4.7.1.2 South Africa Vagus Nerve Stimulation Market by Application
11.4.7.1.3 South Africa Vagus Nerve Stimulation Market by End User
11.4.7.1.4 South Africa Vagus Nerve Stimulation Market by Biomaterial
11.4.7.2 Saudi Arabia Vagus Nerve Stimulation Market
11.4.7.2.1 Saudi Arabia Vagus Nerve Stimulation Market by Product
11.4.7.2.2 Saudi Arabia Vagus Nerve Stimulation Market by Application
11.4.7.2.3 Saudi Arabia Vagus Nerve Stimulation Market by End User
11.4.7.2.4 Saudi Arabia Vagus Nerve Stimulation Market by Biomaterial
11.4.7.3 U.A.E Vagus Nerve Stimulation Market
11.4.7.3.1 U.A.E Vagus Nerve Stimulation Market by Product
11.4.7.3.2 U.A.E Vagus Nerve Stimulation Market by Application
11.4.7.3.3 U.A.E Vagus Nerve Stimulation Market by End User
11.4.7.3.4 U.A.E Vagus Nerve Stimulation Market by Biomaterial
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Vagus Nerve Stimulation Market Overview
11.5.2 South and Central America Vagus Nerve Stimulation Market Forecasts and Analysis
11.5.3 South and Central America Vagus Nerve Stimulation Market Forecasts and Analysis - By Product
11.5.4 South and Central America Vagus Nerve Stimulation Market Forecasts and Analysis - By Application
11.5.5 South and Central America Vagus Nerve Stimulation Market Forecasts and Analysis - By End User
11.5.6 South and Central America Vagus Nerve Stimulation Market Forecasts and Analysis - By Biomaterial
11.5.7 South and Central America Vagus Nerve Stimulation Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Vagus Nerve Stimulation Market
11.5.7.1.1 Brazil Vagus Nerve Stimulation Market by Product
11.5.7.1.2 Brazil Vagus Nerve Stimulation Market by Application
11.5.7.1.3 Brazil Vagus Nerve Stimulation Market by End User
11.5.7.1.4 Brazil Vagus Nerve Stimulation Market by Biomaterial
11.5.7.2 Argentina Vagus Nerve Stimulation Market
11.5.7.2.1 Argentina Vagus Nerve Stimulation Market by Product
11.5.7.2.2 Argentina Vagus Nerve Stimulation Market by Application
11.5.7.2.3 Argentina Vagus Nerve Stimulation Market by End User
11.5.7.2.4 Argentina Vagus Nerve Stimulation Market by Biomaterial
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL VAGUS NERVE STIMULATION MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Rest of the World
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. VAGUS NERVE STIMULATION MARKET, KEY COMPANY PROFILES
14.1. ALEVA NEUROTHERAPEUTICS SA
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. BIOCONTROL MEDICAL
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. BIONESS INC.
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. BOSTON SCIENTIFIC CORPORATION
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. ELECTROCORE LLC
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. ENTEROMEDICS INC.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. LIVANOVA PLC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. MEDTRONIC PLC.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. NEUROPACE INC.
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. NEVRO CORPORATION
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. Aleva Neurotherapeutics SA
2. BioControl Medical
3. Bioness Inc.
4. Boston Scientific Corporation
5. ElectroCore LLC
6. EnteroMedics Inc.
7. LivaNova Plc.
8. Medtronic Plc.
9. NeuroPace Inc.
10. Nevro Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For